Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 6 studies | 33% ± 16% | |
microglial cell | 6 studies | 28% ± 11% | |
epithelial cell | 5 studies | 33% ± 13% | |
oligodendrocyte precursor cell | 5 studies | 30% ± 12% | |
basal cell | 4 studies | 40% ± 22% | |
dendritic cell | 4 studies | 28% ± 20% | |
oligodendrocyte | 4 studies | 28% ± 9% | |
lymphocyte | 3 studies | 19% ± 4% | |
myeloid cell | 3 studies | 23% ± 8% | |
fibroblast | 3 studies | 37% ± 22% | |
macrophage | 3 studies | 40% ± 27% | |
glutamatergic neuron | 3 studies | 31% ± 8% | |
endothelial cell | 3 studies | 23% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 31% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 1982.15 | 245 / 245 | 99% | 6.88 | 499 / 502 |
thymus | 100% | 1498.11 | 653 / 653 | 98% | 6.47 | 594 / 605 |
breast | 100% | 2092.48 | 459 / 459 | 97% | 8.62 | 1087 / 1118 |
ovary | 100% | 2333.16 | 180 / 180 | 97% | 6.30 | 416 / 430 |
uterus | 100% | 2245.10 | 170 / 170 | 96% | 10.82 | 441 / 459 |
intestine | 100% | 1888.57 | 966 / 966 | 96% | 7.81 | 504 / 527 |
stomach | 100% | 1359.69 | 359 / 359 | 94% | 7.41 | 269 / 286 |
kidney | 100% | 1236.00 | 89 / 89 | 93% | 5.71 | 840 / 901 |
liver | 100% | 1234.38 | 226 / 226 | 88% | 3.92 | 359 / 406 |
pancreas | 100% | 1135.66 | 327 / 328 | 88% | 5.92 | 157 / 178 |
adrenal gland | 100% | 1678.44 | 258 / 258 | 87% | 3.95 | 200 / 230 |
lung | 100% | 1613.77 | 576 / 578 | 86% | 6.53 | 999 / 1155 |
esophagus | 100% | 2030.92 | 1445 / 1445 | 85% | 8.09 | 156 / 183 |
skin | 100% | 2306.27 | 1809 / 1809 | 80% | 8.62 | 379 / 472 |
bladder | 100% | 2418.00 | 21 / 21 | 79% | 8.43 | 400 / 504 |
brain | 92% | 702.12 | 2436 / 2642 | 83% | 4.88 | 585 / 705 |
adipose | 100% | 1962.65 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1861.23 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 1772.41 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.85 | 1 / 1 |
muscle | 99% | 811.30 | 792 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 983.02 | 842 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 9.30 | 44 / 45 |
eye | 0% | 0 | 0 / 0 | 93% | 6.22 | 74 / 80 |
lymph node | 0% | 0 | 0 / 0 | 76% | 3.89 | 22 / 29 |
peripheral blood | 55% | 672.57 | 511 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006139 | Biological process | nucleobase-containing compound metabolic process |
GO_0019509 | Biological process | L-methionine salvage from methylthioadenosine |
GO_0033574 | Biological process | response to testosterone |
GO_0006738 | Biological process | nicotinamide riboside catabolic process |
GO_0032259 | Biological process | methylation |
GO_0006166 | Biological process | purine ribonucleoside salvage |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0004645 | Molecular function | 1,4-alpha-oligoglucan phosphorylase activity |
GO_0017061 | Molecular function | S-methyl-5-thioadenosine phosphorylase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | MTAP |
Protein name | Alternative protein MTAP S-methyl-5'-thioadenosine phosphorylase (EC 2.4.2.28) (5'-methylthioadenosine phosphorylase) (MTA phosphorylase) (MTAP) (MTAPase) MTAP Methylthioadenosine phosphorylase MTAP protein Purine nucleoside phosphorylase (PNP) (EC 2.4.2.1) |
Synonyms | HEL-249 MTAP-ANRIL fusion MSAP |
Description | FUNCTION: Catalyzes the reversible phosphorylation of S-methyl-5'-thioadenosine (MTA) to adenine and 5-methylthioribose-1-phosphate. Involved in the breakdown of MTA, a major by-product of polyamine biosynthesis. Responsible for the first step in the methionine salvage pathway after MTA has been generated from S-adenosylmethionine. Has broad substrate specificity with 6-aminopurine nucleosides as preferred substrates. . FUNCTION: Catalyzes the reversible phosphorylation of S-methyl-5'-thioadenosine (MTA) to adenine and 5-methylthioribose-1-phosphate. Involved in the breakdown of MTA, a major by-product of polyamine biosynthesis. Responsible for the first step in the methionine salvage pathway after MTA has been generated from S-adenosylmethionine. Has broad substrate specificity with 6-aminopurine nucleosides as preferred substrates. . FUNCTION: Catalyzes the reversible phosphorylation of S-methyl-5'-thioadenosine (MTA) to adenine and 5-methylthioribose-1-phosphate. Involved in the breakdown of MTA, a major by-product of polyamine biosynthesis. Responsible for the first step in the methionine salvage pathway after MTA has been generated from S-adenosylmethionine. Has broad substrate specificity with 6-aminopurine nucleosides as preferred substrates. . FUNCTION: Catalyzes the reversible phosphorylation of S-methyl-5'-thioadenosine (MTA) to adenine and 5-methylthioribose-1-phosphate. Involved in the breakdown of MTA, a major by-product of polyamine biosynthesis. Responsible for the first step in the methionine salvage pathway after MTA has been generated from S-adenosylmethionine. Has broad substrate specificity with 6-aminopurine nucleosides as preferred substrates. . FUNCTION: Purine nucleoside phosphorylase involved in purine salvage. . FUNCTION: Purine nucleoside phosphorylase involved in purine salvage. . FUNCTION: Catalyzes the reversible phosphorylation of S-methyl-5'-thioadenosine (MTA) to adenine and 5-methylthioribose-1-phosphate. Involved in the breakdown of MTA, a major by-product of polyamine biosynthesis. Responsible for the first step in the methionine salvage pathway after MTA has been generated from S-adenosylmethionine. Has broad substrate specificity with 6-aminopurine nucleosides as preferred substrates. . |
Accessions | ENST00000580900.5 [Q13126-3] J3KRN1 Q13126 Q6FHT1 A0A140CZL4 J3QSB7 Q9NRK7 ENST00000427788.2 L8E7D7 ENST00000419385.5 ENST00000580718.1 A0A2R8Y4K0 ENST00000577563.1 F8WES2 Q6FHP1 Q05DJ2 ENST00000460874.6 ENST00000644715.2 [Q13126-1] B4DUC8 A0A384ME80 |